Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group-Reference-Cited by-同舟云学术

Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group

Published:2023-02 Issue: Volume:58 Page:152110
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Ghosh Nilasha^ORCID,Couette Nina,van Binsbergen Wouter H.,Weinmann Sophia C.,Jivanelli Bridget,Shea Beverley,Bass Anne R.,Benesova Karolina,Bingham Clifton O.,Calabrese Cassandra,Cappelli Laura C.,Chan Karmela Kim,Choy Ernest,Daoussis Dimitrios,Goodman Susan,Hudson Marie,Jamal Shahin,Leipe Jan,Lopez-Olivo Maria A.,Suarez-Almazor Maria,van der Laken Conny J.,Meara Alexa Simon,Liew David,Kostine Marie

Funder

NIAMS

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference22 articles.

1. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat Rev Cancer,2012

2. Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment;Belkhir;Ann Rheum Dis,2017

3. Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer—clinical aspects and relationship with tumour response: a single-centre prospective cohort study;Kostine;Ann Rheum Dis,2017

4. Checkpoint inhibitor–associated arthritis;Ghosh;JCR J Clin Rheumatol,2020

5. Inflammatory arthritis and Sicca syndrome induced by nivolumab and ipilimumab;Cappelli;Ann Rheum Dis,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fostering connections at OMERACT 2023: A collaborative approach to Core Outcome Set development;Seminars in Arthritis and Rheumatism;2024-08

2. Recommendations of the French Society of Rheumatology for the management in current practice of patients with polymyalgia rheumatica;Joint Bone Spine;2024-07

3. Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors: A systematic literature review highlighting differences from the idiopathic forms;Autoimmunity Reviews;2024-07

4. A scoping review of vasculitis as an immune-related adverse event from checkpoint inhibitor therapy of cancer: Unraveling the complexities at the intersection of immunology and vascular pathology;Seminars in Arthritis and Rheumatism;2024-06

5. Recommandations de la Société française de rhumatologie pour la prise en charge en pratique courante des patients atteints de pseudopolyarthrite rhizomélique;Revue du Rhumatisme;2024-06